These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prostacyclin production in internal mammary ano radial arteries and saphenous veins of diabetic and non diabetic subjects]. Guivernau M; Berr M Rev Med Chil; 2008 Jul; 136(7):823-30. PubMed ID: 18949156 [TBL] [Abstract][Full Text] [Related]
3. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery. Friedl R; Li J; Schumacher B; Hanke H; Waltenberger J; Hannekum A; Stracke S Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491 [TBL] [Abstract][Full Text] [Related]
4. [Mechanism of coronary bypass graft disease]. Yang Z; Oemar B; Lüscher TF Schweiz Med Wochenschr; 1993 Mar; 123(10):422-7. PubMed ID: 8456261 [TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]-5-hydroxytryptamine to human coronary artery and bypass graft vessels. Dahm PL; Bodelsson M; Törnebrandt K; Muddle JR; Sykes RM; Yacoub M; Dashwood MR Cardiovasc Res; 1996 May; 31(5):800-6. PubMed ID: 8763410 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency. Tadjkarimi S; O'Neil GS; Luu TN; Allen SP; Schyns CJ; Chester AH; Yacoub MH Cardiovasc Res; 1992 Mar; 26(3):297-300. PubMed ID: 1384972 [TBL] [Abstract][Full Text] [Related]
8. [PGI2-like activity of the internal mammary artery and the saphenous vein used in coronary bypass surgery]. Homolay P; Bordánné Jenes E; Takács EI; Péterffy A Orv Hetil; 1993 Apr; 134(14):731-5. PubMed ID: 8464626 [TBL] [Abstract][Full Text] [Related]
9. Biochemical composition of human internal mammary artery and saphenous vein. Sisto T; Ylä-Herttuala S; Luoma J; Riekkinen H; Nikkari T J Vasc Surg; 1990 Mar; 11(3):418-22. PubMed ID: 2313830 [TBL] [Abstract][Full Text] [Related]
10. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Ray FR; Huang W; Slater M; Barden JA Atherosclerosis; 2002 May; 162(1):55-61. PubMed ID: 11947897 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation. Schlitt A; Pruefer D; Buerke U; Russ M; Dahm M; Oelert H; Werdan K; Buerke M Ann Thorac Surg; 2006 Apr; 81(4):1262-8. PubMed ID: 16564255 [TBL] [Abstract][Full Text] [Related]
12. Prostacyclin production by internal mammary artery as a factor in coronary artery bypass grafts. Subramanian VA; Hernandez Y; Tack-Goldman K; Grabowski EF; Weksler BB Surgery; 1986 Aug; 100(2):376-83. PubMed ID: 3488598 [TBL] [Abstract][Full Text] [Related]
13. Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts. Wendling WW; Krasner LJ; Cooper SC; Chen D; Harakal C; Addonizio VP; Brister NW; Carlsson C J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):717-22. PubMed ID: 11748519 [TBL] [Abstract][Full Text] [Related]
14. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Jabs WJ; Theissing E; Nitschke M; Bechtel JF; Duchrow M; Mohamed S; Jahrbeck B; Sievers HH; Steinhoff J; Bartels C Circulation; 2003 Sep; 108(12):1428-31. PubMed ID: 12975260 [TBL] [Abstract][Full Text] [Related]
15. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein. Broeders MA; Doevendans PA; Maessen JG; van Gorsel E; Egbrink MG; Daemen MJ; Tangelder GJ; Reneman RS; van der Zee R J Thorac Cardiovasc Surg; 2001 Aug; 122(2):305-9. PubMed ID: 11479503 [TBL] [Abstract][Full Text] [Related]
16. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery. Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816 [TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent regulatory mechanisms in human coronary bypass grafts: possible clinical implications. Yang Z; Lüscher TF Z Kardiol; 1989; 78 Suppl 6():80-4. PubMed ID: 2575830 [TBL] [Abstract][Full Text] [Related]
18. Letter regarding article by Khot et al, "Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts" . Shah PJ; Baker RA; Knight JJ Circulation; 2005 Jan; 111(1):e6-9; author reply e6-9. PubMed ID: 15635738 [No Abstract] [Full Text] [Related]
19. Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts. Jett GK; Arcidi JM; Dorsey LM; Hatcher CR; Guyton RA J Thorac Cardiovasc Surg; 1987 Jul; 94(1):2-11. PubMed ID: 3110506 [TBL] [Abstract][Full Text] [Related]
20. Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival. Stevens LM; Carrier M; Perrault LP; Hébert Y; Cartier R; Bouchard D; Fortier A; El-Hamamsy I; Pellerin M J Thorac Cardiovasc Surg; 2004 May; 127(5):1408-15. PubMed ID: 15116000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]